These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

101 related items for PubMed ID: 4423438

  • 21. [Hypertensive crisis: what to do in emergencies?].
    Suwelack B, Welling U, Hohage H.
    Med Klin (Munich); 2004 Sep 15; 99(9):528-35; quiz 536. PubMed ID: 15372182
    [No Abstract] [Full Text] [Related]

  • 22. [Treatment of hypertension].
    Finnish Hypertension Association's task force.
    Duodecim; 2002 Sep 15; 118(1):110-26. PubMed ID: 12228989
    [No Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Re: Efficacy and safety of the single pill combination of amlodipine 10 mg plus valsartan 160 mg in hypertensive patients not controlled by amlodipine 10 mg plus olmesartan 20 mg in free combination.
    Vivencio B.
    Curr Med Res Opin; 2009 Sep 15; 25(9):2267-8; author reply 2268-9. PubMed ID: 19630488
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. [Treatment of the hypertensive syndrome in arterial hypertension].
    Gogin EE.
    Voen Med Zh; 1978 Jun 15; (6):73-5. PubMed ID: 676147
    [No Abstract] [Full Text] [Related]

  • 28. Possibilities for antihypertensive drug therapy withdrawal in the elderly.
    Fotherby MD, Potter JF.
    J Hum Hypertens; 1994 Nov 15; 8(11):857-63. PubMed ID: 7853330
    [Abstract] [Full Text] [Related]

  • 29. Combination therapy as initial treatment for hypertension.
    Neutel JM.
    Manag Care; 2004 Jul 15; 13(7 Suppl):5-11; discussion 12-6. PubMed ID: 15352768
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Felodipine-metoprolol combination tablet: maintained health-related quality of life in the presence of substantial blood pressure reduction.
    Dahlöf B, Degl' Innocenti A, Elmfeldt D, Puig JG, Gundersen T, Hosie J, Januszewicz W, Lindström CJ, Magometschnigg D, Tanser P, Toutouzas P, Waeber B, Wiklund I.
    Am J Hypertens; 2005 Oct 15; 18(10):1313-9. PubMed ID: 16202854
    [Abstract] [Full Text] [Related]

  • 32. [Regression of left ventricular hypertrophy with antihypertensive therapy].
    Follath F.
    Ther Umsch; 1998 Sep 15; 55(9):539-41. PubMed ID: 9789465
    [Abstract] [Full Text] [Related]

  • 33. [Recommendations for therapy of hypertension in general practice and treatment of hypertensive emergencies. German League for Control of Hypertension, Heidelberg].
    Med Monatsschr Pharm; 1993 Nov 15; 16(11):321-4. PubMed ID: 8271999
    [No Abstract] [Full Text] [Related]

  • 34. Prescribing patterns in hypertension: the emerging role of fixed-dose combinations for attaining BP goals in hypertensive patients.
    Neutel JM.
    Curr Med Res Opin; 2008 Aug 15; 24(8):2389-401. PubMed ID: 18616863
    [Abstract] [Full Text] [Related]

  • 35. [Hypotensive agents].
    Ignat'ev MV.
    Feldsher Akush; 1986 Apr 15; 51(4):41-6. PubMed ID: 3639037
    [No Abstract] [Full Text] [Related]

  • 36. [Treatment of scleroderma with unithiol].
    Dubinskiĭ AA, Guida PP.
    Vopr Revm; 1974 Apr 15; (2):54-8. PubMed ID: 4369704
    [No Abstract] [Full Text] [Related]

  • 37. Doxazosin: safety and efficacy in the treatment of resistant arterial hypertension.
    Ceral J, Solar M.
    Blood Press; 2009 Apr 15; 18(1-2):74-7. PubMed ID: 19353415
    [Abstract] [Full Text] [Related]

  • 38. Newer approaches to antihypertensive therapy. Use of fixed-dose combination therapy.
    Epstein M, Bakris G.
    Arch Intern Med; 1996 Sep 23; 156(17):1969-78. PubMed ID: 8823150
    [Abstract] [Full Text] [Related]

  • 39. [Drugs for arterial hypertension].
    Bouyard P.
    Ann Anesthesiol Fr; 1974 Sep 23; 15(1):17-22. PubMed ID: 4466376
    [No Abstract] [Full Text] [Related]

  • 40. Angiotensin converting enzyme inhibition and dihydropyridine calcium channel blockade in the treatment of left ventricular hypertrophy in arterial hypertension.
    Palmieri V, Devereux RB.
    Minerva Cardioangiol; 2002 Jun 23; 50(3):169-74. PubMed ID: 12107398
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.